510(k) Report

FDA applicant

Saranas, Inc.

Houston, TX2 decisions2019–20230 recalls

FDA records 2 decisions for Saranas, Inc. (Houston, TX) from 2019 to 2023: 1 510(k) clearance and 1 De Novo grant. All are in product code QFJ (Intravascular Bleed Monitor). Its devices cite 1 predicate, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Saranas, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2019: 12023: 1
2019high 1 (2019) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2019.

FIG. 1 — Saranas, Inc. by year, 2019–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Saranas, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • QFJIntravascular Bleed Monitor2decisions

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • DEN180021Early Bird Bleed Monitoring SystemSaranas, Inc. · 20191cites it

What has FDA decided for it lately?

  • K230273Saranas Early Bird Bleed Monitoring SystemSaranas, Inc. · 2023
  • DEN180021Early Bird Bleed Monitoring SystemSaranas, Inc. · 2019

All 2 as Saranas, Inc. →